Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 16/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19041309 | 0.86 | SIGMAR1 (0.58) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL29860963 | 0.86 | SIGMAR1 (0.58) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL30487943 | 0.82 | SIGMAR1 (0.54) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL3739484 | 0.82 | SIGMAR1 (0.54) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL30049093 | 0.82 | SIGMAR1 (0.54) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL23833670 | 0.82 | SIGMAR1 (0.54) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL30487948 | 0.82 | SIGMAR1 (0.54) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL30666950 | 0.80 | SIGMAR1 (0.55) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL6269912 | 0.78 | SIGMAR1 (0.51) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL22281808 | 0.78 | HTR2A (0.52) | SIGMAR1ALDH1A1TP53CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969628-B2 | Method for enriching a homogeneous catalyst from a process flow | EVONIK DEGUSSA GMBH (DE) | 2015-03-03 | — | — | US | disclosed |
| EP-2401078-B1 | METHOD FOR ENRICHING A HOMOGENOUS CATALYST FROM A PROCESS FLOW | EVONIK DEGUSSA GMBH (DE) | 2013-10-23 | — | — | EP | disclosed |
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | EVONIK OXENO GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | PARG, PHOSPHO1, COG6 | SIGMAR1 2870/4885ALDH1A1 4227/4885TP53 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.